
Lupus: 5 Questions on Diagnosis
Brush up on the diagnosis of systemic lupus erythematosus with 5 questions based on the recent British Society for Rheumatology guidelines.
In January 2018, the
Question 1
Please click below for answer and next question.
ANSWER: C. 5%
A positive ANA test occurs in 5% of the adult population, and ANAs are present in 95% of patients with SLE.
Question 2
Please click below for answer and next question.
ANSWER: B. Women during the reproductive years
Although SLE can occur at any age, it most frequently presents in women during the reproductive years.
Question 3
Please click below for answer and next question.
ANSWER: A. True.
Survival may be improving, but life expectancy is still poor compared with the general population.
Question 4
Please click below for answer and next question.
ANSWER: D. Anti-Ro/La antibodies
The presence of anti-dsDNA antibodies, low complement levels, or anti-Smith (Sm) antibodies is highly predictive of SLE in patients with relevant clinical features. Anti-Ro/La and anti-RNP antibodies are less specific markers because they are found in other autoimmune rheumatic disorders as well as SLE.
Question 5
Please click below for answer.
ANSWER: A. True
All patients with lupus should be tested for antiphospholipids because their presence indicates an elevated risk of arterial/venous thrombotic events and adverse pregnancy outcomes. Confirmatory tests for antiphospholipid syndrome are positive lupus anticoagulant, anticardiolipin (IgG, IgM), and/or anti-beta-2 glycoprotein-1 (IgG, IgM) on 2 occasions at least 12 weeks apart.
For an overview of the highlights of the guidelines, please see
References:
1. Gordon C, Amissah-Arthur MB, Gayed M, et al, for the British Society for Rheumatology Standards, Audit and Guidelines Working Group.




